When was CraniUS founded?

CraniUS was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is CraniUS located?

CraniUS is headquartered in Baltimore, United States.

How many employees does CraniUS have?

As of May 31, 2026, the latest employee count at CraniUS is 18.

Is CraniUS a funded company?

CraniUS is a funded company, having raised a total of $39.5M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 04, 2021.

When was the latest funding round of CraniUS?

CraniUS's latest funding was a $***** Series B round on Jan 28, 2026, with participation from 0 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $3.08B in funding in 2026 to date.

Where does CraniUS rank among its competitors?

CraniUS ranks 2nd amongst 26 active competitors, of which 6 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Bionxt, which secured $1.43M in Jun, 2026.

Who are the top competitors of CraniUS?

CraniUS's top competitors include Impel NeuroPharma, Cordance Medical and Cognos Therapeutics. Among them, Bionxt secured the most recent funding round in June, 2026.

CraniUS - 2026 Company Profile, Team, Funding & Competitors

Company Details

A medical technology company developing drug delivery systems to treat brain diseases and disorders. It is a technology company that develops implantable devices for brain tumor treatment. Its flagship product, NeuroPASS, is a drug delivery system designed to bypass the blood-brain barrier using precise flow rate of medication directly to the brain for the treatment of aggressive brain tumors, Alzheimer’s, and Parkinson’s disease.

Website: craniustherapeutics.com
Social
Email ID: *****@craniustherapeutics.com

Key Metrics

Founded Year

2021

Location

Baltimore, United States

Stage

Series B

Total Funding

$39.5M in 5 rounds

Latest Funding Round

Series B, Jan 28, 2026, $*****

Investors

Mumbai Angels & 2 more

Ranked

2^nd among 26 active competitors

Employee Count

18 as on May 31, 2026

Similar Companies

Impel NeuroPharma & 28 more

View CraniUS's full profile

CraniUS has raised a total funding of $39.5M over 5 rounds. Its first funding round was on Aug 04, 2021. CraniUS has 3 institutional investors.

Here is the list of recent funding rounds of CraniUS:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 28, 2026	5342153	Series B	2171557	5457273	3098385	5488211
Jan 28, 2026	6023325	Grant (prize money)	8536789	7733655	8561133	Maryland
Jun 26, 2024	7416676	Grant (prize money)	2320024	1488519	5864640	Maryland

Access funding benchmarks and valuations. Sign up today!

View details of CraniUS's funding rounds and investors

The founders of CraniUS are Chad Gordon and Deborah Weidman. Michael Maglin is the CEO of CraniUS.

Here are the details of CraniUS's key team members:

Chad Gordon: Founder & CMO of CraniUS. They serve on the board of 1 company.
Deborah Weidman: Former Co-Founder of CraniUS and founder of 1 other company.
Michael Maglin: CEO of CraniUS.

View details of CraniUS's Founder profiles and Board Members

CraniUS's employee count trend

CraniUS has 18 employees as of May 26. Here is CraniUS's employee count trend over the years:

Uncover CraniUS's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CraniUS include Impel NeuroPharma, Cordance Medical and Cognos Therapeutics. Here is the list of Top 10 competitors of CraniUS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Impel NeuroPharma 2008, Seattle (United States), Public	Developer of an intranasal drug delivery technology for CNS diseases	$120M	VenBio, Vivo Capital & 7 others	63/100
2nd	CraniUS 2021, Baltimore (United States), Series B	A medical technology company developing drug delivery systems to treat brain diseases and disorders	$39.5M	Lumis Partners, Maryland & 1 others	59/100
3rd	Cordance Medical 2018, Mountain View (United States), Seed	Developer of a non-invasive medical device to open the blood-brain barrier	$8M	Sonder Capital, WPSS.bio & 11 others	53/100
4th	Cognos Therapeutics 2015, Los Angeles (United States), Series A	Provider of an implantable device designed to deliver therapeutic drugs	$5.75M	-	43/100
5th	Bionxt 2018, Vancouver (Canada), Public	Developer of drug formulations and delivery systems for various diseases	-	Planet Ventures	43/100
6th	MedVasc 2013, Lund (Sweden), Series A	Providing a surgical tool for intraoperative drug delivery	$3.65M	Smile Incubator	42/100
7th	Neurochase 2020, Cardiff (United Kingdom), Unfunded	Developer of a drug delivery technology for CNS therapeutics	-	-	36/100
8th	NsGene 1999, Ballerup (Denmark), Deadpooled	Drug delivery systems and therapeutics for CNS diseases.	$5.14M	Sunstone, Omega Funds & 5 others	31/100
9th	SiNON 2015, Durham (United States), Funding Raised	Developer of nanoparticle based drug delivery paltform	-	Bantam Group, First Flight Venture Center ... & 1 others	30/100
10th	Altucell 2010, Babylon (United States), Acquired	Developer of regenerative therapy for neurodegenerative diseases	-	-	29/100